FaCellitate Overview
- Year Founded
-
2021
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
FaCellitate General Information
Description
Developer of biomedical technology designed to support cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The company offers chemically defined, animal- and xeno-free cell culture coatings for 3D cell culture and stem cell research, enabling researchers to run experiments on smart lab surfaces.
Contact Information
Website
www.facellitate.com(Operating Subsidiary)
Corporate Office
- Franz-Volhard-Straße 5
- 68167 Mannheim
- Germany
Corporate Office
- Franz-Volhard-Straße 5
- 68167 Mannheim
- Germany
FaCellitate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 16-Nov-2026 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 13-Apr-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 07-Sep-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 1. Spin-Off | 01-Jan-2021 | Completed | Generating Revenue |
FaCellitate Patents
FaCellitate Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024225071-A1 | Cell attachment polymer conjugate | Pending | 23-Feb-2023 | ||
| EP-4669741-A1 | Cell attachment polymer conjugate | Pending | 23-Feb-2023 | ||
| WO-2024175790-A1 | Cell attachment polymer conjugate | Inactive | 23-Feb-2023 | ||
| WO-2023089165-A1 | Photobioreactor with an adsorbed layer of antifouling cationic comb copolymer | Inactive | 22-Nov-2021 | ||
| WO-2023089167-A1 | Photobioreactor with an adsorbed layer of antifouling zwitterionic copolymer | Inactive | 22-Nov-2021 | C12M21/02 |
FaCellitate Signals
FaCellitate Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arve Capital | Venture Capital | Minority | ||
| Chemovator | Accelerator/Incubator | Minority | ||
| German Accelerator | Accelerator/Incubator | |||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| NEXT Mannheim | Accelerator/Incubator |
FaCellitate FAQs
-
When was FaCellitate founded?
FaCellitate was founded in 2021.
-
Where is FaCellitate headquartered?
FaCellitate is headquartered in Mannheim, Germany.
-
What is the size of FaCellitate?
FaCellitate has 13 total employees.
-
What industry is FaCellitate in?
FaCellitate’s primary industry is Discovery Tools (Healthcare).
-
Is FaCellitate a private or public company?
FaCellitate is a Private company.
-
What is FaCellitate’s current revenue?
The current revenue for FaCellitate is .
-
How much funding has FaCellitate raised over time?
FaCellitate has raised $3.72M.
-
Who are FaCellitate’s investors?
Arve Capital, Chemovator, German Accelerator, High-Tech Gründerfonds, and NEXT Mannheim are 5 of 8 investors who have invested in FaCellitate.
-
When was FaCellitate acquired?
FaCellitate was acquired on 16-Nov-2026.
-
Who acquired FaCellitate?
FaCellitate was acquired by Sarstedt.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process